Denmark has successfully tested a new anti-obesity drug

A new weight loss medication is more effective than all the modern equivalents. The centers of the brain responsible for appetite, it causes a feeling of fullness soon after the start of a meal, reports the Daily Mail. Tezofenzin drug, originally developed by the Danish pharmaceutical company NeuroSearch as a treatment for Parkinson's disease and Alzheimer's disease, works by blocking the rear of neuronal uptake of serotonin, dopamine and norepinephrine in the brain structures that regulate feelings of hunger and satiety. A study was conducted by Professor of the University of Copenhagen, the president of the International Association for the Study of Obesity Arne Astrup, showed that after six months of taking the drug at a dose of 0.5 mg once daily body weight by an average of 9.18 % reduced. This is about twice as much as the use of the currently available drugs. Increasing doses lead to increased side effects, and the reduction - to reduce the efficiency. After Astrup, can tezofenzina combination with diet and exercise weight loss up to 20% in six months. Tezofenzina side effects were generally mild and transient and included nausea, diarrhea, constipation, insomnia, mood swings, and the causes. Greatest fear, increased heart rate The next phase of clinical tests will show whether the benefits of the drug from the potential risks associated with their use outweigh connected. If trials are successful, could tezofenzin go on sale in three years.